竞博电竞登录直播官网_竞博电竞登录比分

Breaking news on biotech stocks and catalysts which includes FDA announcements, license agreements, and clinical trial data releases.

Aurinia Pharmaceuticals $AUPH Stock Up On Buyout Rumors

January 21, 2022 Lance Jepsen Analysts Activity , Biotechnology

Buyout rumors are once again circulating about AUPH stock on January 21, 2022. The rumors appear to be circulating from a STAT article published on

Novavax $NVAX Stock Up On Australia Approval of COVID-19 Vaccine

January 20, 2022 Lance Jepsen Biotechnology

NVAX stock rose in morning trade on January 20, 2022, after Australia granted provisional registration for Novavax’s COVID-19 vaccine. Australia Therapeutic Goods Administration (TGA) Grants

ChemoCentryx $CCXI Stock Up On EU Approval of Tavneos

January 19, 2022 Lance Jepsen Biotechnology

CCXI stock rose 5% in early trading on January 19, 2022, after the company announced that the EU approved Tavneos. ChemoCentryx Announces EU Approval of

ImmunityBio $IBRX Stock Up 11.5% In After-hours On Blockbuster Clinical Trial Data

January 18, 2022 Lance Jepsen Biotechnology

IBRX stock rose 11.5% in after-hours trading on January 18, 2022, after the company reported trial incredibly awesome results on its pancreatic cancer study. ImmunityBio

Ocugen $OCGN Stock Basing On Covaxin Destroying Delta and Omicron

January 15, 2022 Lance Jepsen Biotechnology , Coronavirus

OCGN stock may be basing as of January 15, 2022, after the company announced its vaccine candidate was effective against delta and omicron. COVAXIN™ (BBV152)